Altered expression of neprilysin family members in the pituitary gland of sleep-disturbed rats, an animal model of severe fatigue

Journal of Neurochemistry

Volumn 95, Issue 4, 2005, Pages 1156-1166

  Ogawa, Tokiko ^a   Kiryu Seo, Sumiko ^a   Tanaka, Masaaki ^a   Konishi, Hiroyuki ^a   Iwata, Nobuhisa ^b   Saido, Takaomi ^b   Watanabe, Yasuyoshi ^a   Kiyama, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Damage induced neuronal endopeptidase; ECEL1; Endothelin converting enzyme 1; Fatigue; Galanin; Metallopeptidase

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATIGUE; HYPOPHYSIS CELL; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP DISORDER;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; AORTA; BLOTTING, NORTHERN; BRAIN; DISEASE MODELS, ANIMAL; FATIGUE; FLUORESCENT ANTIBODY TECHNIQUE; GALANIN; GENE EXPRESSION REGULATION; GROWTH HORMONE; KIDNEY; LUTEINIZING HORMONE; MALE; METALLOENDOPEPTIDASES; MYOCARDIUM; NEPRILYSIN; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; SLEEP DISORDERS; THYROTROPIN; TIME FACTORS;

ANIMALIA;

EID: 28244454638     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03436.x     Document Type: Article

References (46)

1. Abassi Z. A., Golomb E., Agbaria R., Roller P. P., Tate J. and Keiser H. R. (1994) Hydrolysis of iodine labelled urodilatin and ANP by recombinant neutral endopeptidase EC 3.4.24.11. Br. J. Pharmacol. 113, 204-208.
2. Aberdam E., Auberger P., Ortonne J. P. and Ballotti R. (2000) Neprilysin, a novel target for ultraviolet B regulation of melanogenesis via melanocortins. J. Invest. Dermatol. 115, 381-387.
3. Bames K., Doherty S. and Turner A. J. (1995) Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J. Neurochem. 64, 1826-1832.
4. Bennett A. L., Chao C. C., Hu S., Buchwald D., Fagioli L. R., Schur P. H., Peterson P. K. and Komaroff A. L. (1997) Elevation of bioactive transforming growth factor-β in serum from patients with chronic fatigue syndrome. J. Clin. Immunol. 17, 160-166.
5. Bredow S., Kacsoh B., Obal F. Jr, Fang J. and Krueger J. M. (1994) Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP. Brain Res. 660, 301-308.
6. Cleare A. J. (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 24, 236-252.
7. Deschodt-Lanckman M., Vanneste Y., Loir B., Michel A., Libert A., Ghanem G. and Lejeune F. (1990) Degradation of α-melanocyte stimulating hormone (α-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int. J. Cancer 46, 1124-1130.
8. Everson C. A. and Nowak T. S. Jr (2002) Hypothalamic thyrotropin- releasing hormone mRNA responses to hypothyroxinemia induced by sleep deprivation. Am. J. Physiol. Endocrinol. Metab. 283, E85-E93.
9. Facchinetti P., Rose C., Schwartz J. C. and Ouimet T. (2003) Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelin-converting enzyme-1. Neuroscience 118, 627-639.
10. Fukuda K., Straus S. E., Hickie I., Sharpe M. C., Dobbins J. G. and Komaroff A. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 121, 953-959.
11. Galas L., Tonon M. C., Beaujean D. et al. (2002) Neuropeptide Y inhibits spontaneous α-melanocyte-stimulating hormone (α-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced α-MSH secretion via a Y(1) receptor in frog melanotrope cells. Endocrinology 143, 1686-1694.
12. Gee N. S., Bowes M. A., Buck P. and Kenny A. J. (1985) An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem. J. 228, 119-126.
13. Gourlet P., Vandermeers A., Robberecht P. and Deschodt-Lanckman M. (1997). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11. Biochem. Pharmacol. 54, 509-515.
14. Inoue K., Yamazaki H., Manabe Y., Fukuda C., Hanai K. and Fushiki T. (1999) Transforming growth factor-β activated during exercise in brain depresses spontaneous motor activity of animals: relevance to central fatigue. Brain Res. 846, 145-153.
15. Iwata N., Tsubuki S., Takaki Y et al. (2000) Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
16. Iwata N., Tsubuki S., Takaki Y et al. (2001) Metabolic regulation of brain A by neprilysin. Science 292, 1550-1552.
17. Iwata N., Takaki Y., Fukami S., Tsubuki S. and Saido T. C. (2002) Region-specific reduction of Aβeta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70, 493-500.
18. Kato R., Kiryu-Seo S. and Kiyama H. (2002) Damage-induced neuronal endopeptidase (DINE/ECEL) expression is regulated by leukemia inhibitory factor and deprivation of nerve growth factor in rat sensory ganglia after nerve injury. J. Neurosci. 22, 9410-9418.
19. Kiryu S., Yao G. L., Monta N., Kato H. and Kiyama H. (1995) Nerve injury enhances rat neuronal glutamate transporter expression: identification by differential display PCR. J. Neurosci. 15, 7872-7878.
20. Kiryu-Seo S. and Kiyama H. (2004) DINE (damage-induced neuronal endopeptidase). Protein Pept. Lett. 11, 451-460.
21. Kiryu-Seo S., Sasaki M., Yokohama H., Nakagomi S., Hirayama T., Aoki S., Wada K. and Kiyama H. (2000) Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers. Proc. Natl Acad. Sci. USA 97, 4345-4350.
22. Kuratsune H., Yamaguti K., Lindh G. et al. (2002) Brain regions involved in fatigue sensation: reduced acetylcamitine uptake into the brain. Neuroimage 17, 1256-1265.
23. Lew R. A. (2004) The zinc metallopeptidase family: new faces, new functions. Protein Pept. Lett. 11, 407-414.
24. Llorens-Cortes C., Huang H., Vicart P., Gasc J. M., Paulin D. and Corvol P. (1992) Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J. Biol. Chem. 267, 14 012-14 018.
25. Matsas R., Kenny A. J. and Turner A. J. (1984) The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem. J. 223, 433-440.
26. Medeiros Mdos S. and Turner A. J. (1996) Metabolism and functions of neuropeptide Y. Neurochem. Res. 21, 1125-1132.
27. Mumford R. A., Pierzchala P. A., Strauss A. W. and Zimmerman M. (1981) Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc. Natl Acad. Sci. USA 78, 6623-6627.
28. Nakagomi S., Kiryu-Seo S. and Kiyama H. (2000) Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury. Neuroscience 101, 441-449.
29. O'Donnell-Tormey J. and Quigley J. P. (1983) Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc. Natl Acad. Sci. USA 80, 344-348.
30. Ogawa T., Hagihara K., Suzuki M. and Yamaguchi Y. (2001) Brevican in the developing hippocampal fimbria: differential expression in myelinating oligodendrocytes and adult astrocytes suggests a dual role for brevican in central nervous system fiber tract development. J. Comp. Neurol. 432, 285-295.
31. Ohba N., Kiryu-Seo S., Maeda M., Muraoka M., Ishii M. and Kiyama H. (2004) Expression of damage-induced neuronal endopeptidase (DINE) mRNA in peri-infarct cortical and thalamic neurons following middle cerebral artery occlusion. J. Neurochem. 91, 956-964.
32. Opp M. R., Obal F. Jr, and Krueger J. M. (1988) Effects of α-MSH on sleep, behavior, and brain temperature: interactions with IL-1. Am. J. Physiol. 255, R914-R922.
33. Ouimet T., Facchinetti P., Rose C., Bonhomme M. C., Gros C. and Schwartz J. C. (2000) Neprilysin II: a putative novel metalloprotease and its isoforms in CNS and testis. Biochem. Biophys. Res. Commun. 271, 565-570.
34. Parker A. J., Wessely S. and Cleare A. J. (2001) The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 31, 1331-1345.
35. Roques B. P., Foumie-Zaluski M. C., Soroca E., Lecomte J. M., Malfroy B., Llorens C. and Schwartz J. C. (1980) The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288, 286-288.
36. Shen R., Sumitomo M., Dai J. et al. (2000) Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Mol. Cell Endocrinol. 170, 131-142.
37. Shimada K., Takahashi M. and Tanzawa K. (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol Chem. 269, 18 275-18 278.
38. Steiger A. (2002) Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Med. Rev. 6, 125-138.
39. Steiger A. (2003) Sleep and endocrine regulation. Front Biosci. 8, s358-s376.
40. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Nozaki S. and Watanabe Y. (2003) Establishment and assessment of a rat model of fatigue. Neurosci. Lett. 352, 159-162.
41. Tharaux P. L., Stefanski A., Ledoux S., Soleilhac J. M., Ardaillou R. and Dussaule J. C. (1997) EGF and TGF-β regulate neutral endopeptidase expression in renal vascular smooth muscle cells. Am. J. Physiol 272, C1836-C1843.
42. Turner A. J. and Tanzawa K. (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11, 355-364.
43. Turner A. J., Isaac R. E. and Coates D. (2001) The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 23, 261-269.
44. Valdenaire O., Richards J. G., Faull R. L. and Schweizer A. (1999) XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS. Mol. Brain Res. 64, 211-221.
45. Wilcox J. N., Pollard H., Moreau J., Schwartz J. C. and Malfroy B. (1989) Localization of enkephalinase mRNA in rat brain by in situ hybridization: comparison with immunohistochemical localization of the protein. Neuropeptides 14, 77-83.
46. Yamamoto K., Chappell M. C., Brosnihan K. B. and Ferrario C. M. (1992) In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19, 692-696.